FDA 要求 Covid 疫苗制造商扩大对罕见心脏炎症风险的警告
FDA requires Covid vaccine makers to expand warnin
FDA requires Covid vaccine makers to expand warnin
The FDA is circumventing key roles and procedures
•26岁或以下的成年人
•27至45岁的成年人,基于共同的临床决策。(注意:尽管许多27-45岁的成年人以前接触过1种或多种人乳头瘤病毒病毒疫苗,但大多数人没有接触过疫苗中包含的所有9种人乳头瘤病毒病毒。此外,在任何年龄,有新的性伴侣都是暴露于新的人乳头瘤病毒感染的风险因素。)
•11岁或12岁(如果愿意,可以从9岁或10岁开始)
•未完成人乳头瘤病毒疫苗接种系列的13至26岁人群
•9岁及以上,有任何性虐待或性侵犯史
常规轮状病毒疫苗接种
•年龄从6周至14周,6天者未开始接种一系列轮状病毒疫苗
•未完成一系列轮状病毒疫苗接种的8个月、0天或以下儿童
Availability of flu vaccines, 2022 这显示了每个国家的公共或私营部
Respiratory death rate from seasonal influenza, ag
National policy on flu vaccination for older peopl
H5N1 influenza: monthly reported cases H5N1 influe
Flu vaccination coverage in the over-65’s, 2
Flu vaccination coverage in older people, 2022 这显示
Yale Medicine Genital Herpes •一种性传播感染,可引起生殖器疼痛和溃疡
Tina Tan, MD, comments on FDA expanded approval fo
FDA approves MenQuadfi meningococcal vaccine for c
Study reveals distinct long COVID symptom patterns
Nirsevimab demonstrates sustained efficacy in redu
Expert reactions to new COVID-19 vaccine policies
CDC pulls COVID-19 vaccine recommendation for heal
The economic cost of vaccine hesitancy — it’s expe
Moderna Receives U.S. FDA Approval for COVID-19 Va
Leprosy was an American scourge long before Europe
Norovirus vaccine produces mucosal immunity in pha
Prior COVID vaccination produces immune response a
Beyfortus public health advantage bolstered by fir
WHO position paper on immunization to protect infa